These correlation analyses of our dataset showed that patients with TNBC (n = 32) overexpressing Prune-1 were also characterized by higher numbers of tumor-infiltrating TAMs (i.e., CD68+ cells; Figure 5D, g–h; p = 0.014, R = 0.433; in Table 6) and with a trend to significant association with CD163+ cells (p = 0.07, R = 0.32; see Figure 5D, i–l), a marker of pro-tumorigenic M2-polarized TAMs (Spano and Zollo, 2012), and with FOXP3, a marker of Tregs (p = 0.08; see Figure 5D, m–n). The gene discussed is CD163; the disease is neoplasm.